S. Gates, G. D. Perkins, S. E. Lamb et C. Kelly, « Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome », Health Technology Assessment (Winchester, England), vol. 17, no 38, , v–vi, 1–87 (ISSN2046-4924, PMID24028755, PMCID4781532, DOI10.3310/hta17380, lire en ligne, consulté le )
S. Gates, G. D. Perkins, S. E. Lamb et C. Kelly, « Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome », Health Technology Assessment (Winchester, England), vol. 17, no 38, , v–vi, 1–87 (ISSN2046-4924, PMID24028755, PMCID4781532, DOI10.3310/hta17380, lire en ligne, consulté le )
S. Gates, G. D. Perkins, S. E. Lamb et C. Kelly, « Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome », Health Technology Assessment (Winchester, England), vol. 17, no 38, , v–vi, 1–87 (ISSN2046-4924, PMID24028755, PMCID4781532, DOI10.3310/hta17380, lire en ligne, consulté le )
S. Gates, G. D. Perkins, S. E. Lamb et C. Kelly, « Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome », Health Technology Assessment (Winchester, England), vol. 17, no 38, , v–vi, 1–87 (ISSN2046-4924, PMID24028755, PMCID4781532, DOI10.3310/hta17380, lire en ligne, consulté le )